TSXV - Delayed Quote CAD

Voyageur Pharmaceuticals Ltd. (VM.V)

0.1750

0.0000

(0.00%)

At close: April 25 at 3:25:02 PM EDT

Voyageur Launches Market Introduction of Barium Contrast Product Line Following Successful Clinical Study Results

CALGARY, ALBERTA - April 23, 2025 (NEWMEDIAWIRE) - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) ("Voyageur" or the "Company") a radiology contrast media company focused on vertical integration and secure supply chains, is pleased to anno...

NewMediaWire 4 days ago

VYYRF
Voyageur Completes Human Testing of Barium Contrast Products and Prepares for Canadian Market Launch

CALGARY, ALBERTA - April 1, 2025 (NEWMEDIAWIRE) - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) ("Voyageur" or the "Company") is pleased to announce the successful completion of a key phase in human testing of its Health Canada-licensed b...

NewMediaWire 26 days ago

VYYRF
TSX Penny Stocks To Watch In March 2025

As the Canadian market navigates a period of economic adjustment, with inflation rising to 2.6% in February due to tax changes, investors are keeping a close watch on interest rate policies and their implications for growth. Penny stocks, often associated with smaller or newer companies, remain an intriguing investment area despite being considered somewhat niche today. With strong financials as a key criterion, these stocks can offer unique opportunities for those looking beyond larger firms...

Simply Wall St. last month

VYYRF

RROTF

YNVYF
Voyageur Pharmaceuticals Advances Frances Creek Project, Paving the Way for a Secure, Vertically Integrated Barium Contrast Product Line

CALGARY, ALBERTA - March 4, 2025 (NEWMEDIAWIRE) - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) ("Voyageur" or the "Company") is pleased to announce the commencement of the Frances Creek barium contrast media project, powered by a $600,00...

NewMediaWire last month

VYYRF
Voyageur Clarifies Terms of Previously Announced Agreement

Calgary, Alberta--(Newsfile Corp. - March 3, 2025) - Voyageur Pharmaceuticals Ltd. (TSXV: VM) (OTC Pink: VYYRF) ("Voyageur" or the "Company") wishes to clarify the terms of a distribution and wholesaling agreement (the "Agreement") it previously announced on May 28, 2024, and referred to subsequently in news releases dated January 15 and 23, 2025.On May 28, 2024, the Company issued a news release in which it announced the Agreement with a sales commitment of USD ...

Newsfile last month

VYYRF
Voyageur Advances MRI Drug Development Using Next Generation Endohedral Fullerenes

CALGARY, ALBERTA - February 18, 2025 (NEWMEDIAWIRE) - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) ("Voyageur" or the "Company") is pleased to announce the launch of its next generation MRI contrast agent development program in collabora...

NewMediaWire 2 months ago

VYYRF
Voyageur Receives $600K Grant From Alberta Innovates for Product Development

CALGARY, ALBERTA - February 5, 2025 (NEWMEDIAWIRE) - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) ("Voyageur" or the "Company") is excited to announce its receipt of a $600,000 grant from Alberta Innovates ("Alberta Innovates"), a provin...

NewMediaWire 2 months ago

VYYRF
Voyageur Secures $687k of Additional Capital From Warrant Exercises

CALGARY, ALBERTA - January 23, 2025 (NEWMEDIAWIRE) - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) ("Voyageur" or the "Company"), a company planning to vertically integrate the medical imaging industry, is pleased to announce that it has ...

NewMediaWire 3 months ago

VYYRF
Voyageur Recaps Significant 2024 Achievements and Unveils Plans for Transformational 2025, Including Market Launch for Barium Suite of Products and Advancement of Iodine Suite

CALGARY, ALBERTA - January 15, 2025 (NEWMEDIAWIRE) - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) ("Voyageur" or the "Company"), a company vertically integrating the medical imaging industry, is pleased to recap a series of achievements ...

NewMediaWire 3 months ago

VYYRF
3 TSX Penny Stocks With At Least CA$3M Market Cap

As we navigate 2025, the Canadian market is experiencing shifts driven by rising government bond yields and political changes, which have influenced stock valuations across various sectors. In this context, identifying promising investment opportunities requires a focus on fundamentals and financial strength. Penny stocks, though often seen as speculative due to their smaller size or newer status, can still offer significant value when backed by robust financials and growth potential.

Simply Wall St. 3 months ago

JORFF

CGTRF

VYYRF
Voyageur Commences Testing of Innovative Barium Contrast Product Line in Human Radiology Scans, Paving the Way for Near-Term Market Launch

CALGARY, ALBERTA - January 13, 2025 (NEWMEDIAWIRE) - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) ("Voyageur" or the "Company") is pleased to announce that it has begun human testing on its latest barium contrast suite of products (as ou...

NewMediaWire 3 months ago

VYYRF
Voyageur Announces Closing of Final Tranche of Private Placement

CALGARY, Alberta - (NewMediaWire) - December 18, 2024 - Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (OTC: VYYRF) ("Voyageur" or the "Corporation"), is pleased to announce that, further to its news releases of October 17, November 26, and December 3, 20...

NewMediaWire 4 months ago

VYYRF
Top TSX Penny Stocks To Watch In December 2024

The Canadian market has been experiencing a dynamic period, with investors closely monitoring economic trends and portfolio strategies to align with their long-term financial goals. For those interested in smaller or newer companies, penny stocks—despite the term's somewhat outdated connotation—remain relevant as an investment area offering potential value. This article will explore several penny stocks that stand out for their financial strength, making them intriguing options for investors...

Simply Wall St. 4 months ago

VYYRF

EMUSF

STXPF
CMC Metals And 2 Other TSX Penny Stocks With Promising Prospects

The Canadian market has been experiencing significant shifts following the decisive U.S. election outcome, which alleviated some uncertainties and led to a notable post-election rally. In light of these changes, investors are increasingly focusing on long-term fundamentals and opportunities within various sectors. Penny stocks, while an older term, continue to represent intriguing prospects for those interested in smaller or newer companies with potential growth opportunities at lower price...

Simply Wall St. 5 months ago

ROMJF

VYYRF

CMCXF
Voyageur Announces Proposed Private Placement

Calgary, Alberta--(Newsfile Corp. - October 17, 2024) - Voyageur Pharmaceuticals Ltd. (TSXV: VM) (OTC Pink: VYYRF) ("Voyageur" or the "Corporation"), is pleased to announce a proposed non-brokered private placement of up to 16,666,667 units ("Units") at a price of $0.06 per Unit, for gross proceeds of up to CND$1,000,000 (the "Offering"). There is no minimum Offering. Each Unit shall be comprised of one common share in the capital of the Corporation (each, a "Common ...

Newsfile 6 months ago

VYYRF
Voyageur Pharmaceuticals Grants Stock Options

Calgary, Alberta--(Newsfile Corp. - September 25, 2024) - Voyageur Pharmaceuticals Ltd. (TSXV: VM) (OTC Pink: VYYRF) ("Voyageur" or the "Company") announces that it has granted an aggregate of 600,000 stock options (the "Options") to officers of the Company pursuant to its incentive stock option plan. The Options were granted at an exercise price of $0.06 per share, vest immediately, and have a 10-year term. The Options are subject to regulatory and TSX Venture Exchange ...

Newsfile 6 months ago

VYYRF
Update - Voyageur Pharmaceuticals Ltd Secures USD $1.9 Million Sales Contract for SmoothX 2% Barium Contrast

CALGARY, Canada - (NewMediaWire) - May 28, 2024 - Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (USA: VYYRF) ("Voyageur" or the "Company") proudly announces its first international distribution agreement with a sales commitment of USD $1.9 million (CAD $...

NewMediaWire 10 months ago

VYYRF
Voyageur Pharmaceuticals Ltd Signs Radiology Drug Sales Contract Valued at $USD 1.9 Million for SmoothX 2% Barium Contrast

CALGARY, Canada - (NewMediaWire) - May 27, 2024 - Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (USA: VYYRF) ("Voyageur" or the "Company") proudly announces signing its first sales contract valued at USD $1.9 million (approximately CAD $2.6). The contrac...

NewMediaWire 10 months ago

VYYRF

Performance Overview

Return	VM.V	S&P/TSX Composite index (^GSPTSE)
YTD	+105.88%	+0.37%
1-Year	+250.00%	+12.91%
3-Year	+75.00%	+17.60%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Voyageur Pharmaceuticals Ltd. (VM.V)

Voyageur Launches Market Introduction of Barium Contrast Product Line Following Successful Clinical Study Results

Voyageur Completes Human Testing of Barium Contrast Products and Prepares for Canadian Market Launch

TSX Penny Stocks To Watch In March 2025

Voyageur Pharmaceuticals Advances Frances Creek Project, Paving the Way for a Secure, Vertically Integrated Barium Contrast Product Line

Voyageur Clarifies Terms of Previously Announced Agreement

Voyageur Advances MRI Drug Development Using Next Generation Endohedral Fullerenes

Voyageur Receives $600K Grant From Alberta Innovates for Product Development

Voyageur Secures $687k of Additional Capital From Warrant Exercises

Voyageur Recaps Significant 2024 Achievements and Unveils Plans for Transformational 2025, Including Market Launch for Barium Suite of Products and Advancement of Iodine Suite

3 TSX Penny Stocks With At Least CA$3M Market Cap

Voyageur Commences Testing of Innovative Barium Contrast Product Line in Human Radiology Scans, Paving the Way for Near-Term Market Launch

Voyageur Announces Closing of Final Tranche of Private Placement

Top TSX Penny Stocks To Watch In December 2024

CMC Metals And 2 Other TSX Penny Stocks With Promising Prospects

Voyageur Announces Proposed Private Placement

Voyageur Pharmaceuticals Grants Stock Options

Update - Voyageur Pharmaceuticals Ltd Secures USD $1.9 Million Sales Contract for SmoothX 2% Barium Contrast

Voyageur Pharmaceuticals Ltd Signs Radiology Drug Sales Contract Valued at $USD 1.9 Million for SmoothX 2% Barium Contrast

Performance Overview